Vezeeta Funding: How Much Did They Raise & Key Investors

How Much Did Vezeeta Raise?
Funding & Key Investors

Vezeeta, a prominent player in the digital health sector, has successfully secured significant capital to bolster its market position. With a cumulative investment reaching $17M, the company continues to demonstrate robust growth trajectories within the competitive healthcare technology landscape. The most recent financing round, totaling $0, underscores the firm's ongoing commitment to scaling its operations and enhancing its digital infrastructure for patients and providers alike.

This latest infusion of capital serves as a testament to the company's resilience and its ability to attract institutional backing even in complex economic climates. By leveraging these resources, Vezeeta is well-positioned to solidify its footprint in the MENA region and beyond, ensuring that its practice management software remains at the forefront of medical innovation.

What is Vezeeta?

Vezeeta

Software

Healthcare Software

Mobile App Development

Founded in 2012 and headquartered in Cairo, Egypt, Vezeeta operates as a sophisticated digital healthcare booking platform and practice management software provider. The company bridges the gap between patients and medical professionals, streamlining the appointment scheduling process while providing doctors with essential tools to manage their clinical workflows efficiently. By digitizing the patient-provider interaction, Vezeeta has effectively transformed the regional healthcare delivery model, moving it away from fragmented, manual processes toward a centralized, data-driven ecosystem. Its market position is defined by its ability to integrate seamlessly into existing medical practices, thereby increasing operational efficiency and improving patient access to quality care.

How much funding has Vezeeta raised?

Vezeeta has raised a total of $17M across 2 funding rounds:

2016

Series B

$5M

2018

Series C

$12M

Series B (2016): $5M with participation from Vostok New Ventures and BECO Capital

Series C (2018): $12M, investors not publicly disclosed

Key Investors in Vezeeta

Vostok New Ventures

VNV Global is an investment firm that focuses on combining patient capital with network effect businesses to achieve long-term profitability.

BECO Capital

A venture capital firm specializing in early-stage and growth-stage investments within the MENA region, focusing on technology-driven startups.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Vezeeta?

Looking ahead, the strategic deployment of the $0 will likely focus on aggressive market expansion and the enhancement of the platform's core technological capabilities. As the company transitions into a more mature enterprise-level entity, the focus will shift toward deepening its integration with regional health systems and potentially exploring new service verticals such as telemedicine or integrated pharmacy solutions. The objective is to create a comprehensive, end-to-end digital health journey that addresses the evolving needs of a growing user base. By maintaining a focus on scalability and user-centric design, Vezeeta is poised to maintain its competitive advantage and continue its trajectory as a cornerstone of the digital health infrastructure in its target markets.

See full Vezeeta company page

See More Financial Insights